Search hospitals > Maryland > Baltimore
Mercy Medical Center
Claim this profileBaltimore, Maryland 21202
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Hepatitis
Conducts research for Hepatitis C
Conducts research for Liver Cirrhosis
219 reported clinical trials
5 medical researchers
Summary
Mercy Medical Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Breast Cancer, Cancer, Hepatitis, Hepatitis C, Liver Cirrhosis and other specialties. Mercy Medical Center is involved with conducting 219 clinical trials across 297 conditions. There are 5 research doctors associated with this hospital, such as David Riseberg, Paul Thuluvath, MBBS, MD, FRCP, Neil B. Friedman, and Teresa Diaz-Montes, M.D., M.P.H.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Cancer
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
David RisebergMercy Medical Center1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
11 reported clinical trials
23 drugs studied
Paul Thuluvath, MBBS, MD, FRCPMercy Medical Center3 years of reported clinical research
Studies Liver Cirrhosis
Studies Non-alcoholic Fatty Liver Disease
7 reported clinical trials
10 drugs studied
Neil B. FriedmanMercy Medical Center12 years of reported clinical research
Studies Breast Cancer
1 reported clinical trial
1 drug studied
Teresa Diaz-Montes, M.D., M.P.HMercy Medical Center10 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
1 reported clinical trial
6 drugs studied
Clinical Trials running at Mercy Medical Center
Breast Cancer
Liver Cirrhosis
Liver Disease
Cholangitis
Primary Biliary Cirrhosis
Non-alcoholic Fatty Liver Disease
Hepatitis
Inflammatory Bowel Disease
Cancer
Fatty Liver Disease
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mercy Medical Center?
Mercy Medical Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Breast Cancer, Cancer, Hepatitis, Hepatitis C, Liver Cirrhosis and other specialties. Mercy Medical Center is involved with conducting 219 clinical trials across 297 conditions. There are 5 research doctors associated with this hospital, such as David Riseberg, Paul Thuluvath, MBBS, MD, FRCP, Neil B. Friedman, and Teresa Diaz-Montes, M.D., M.P.H.